CD70 and renal cell carcinoma: In other words, even if the anti-CD70 antibodies were to efficaciously target IFN-γ to RCC cells, the selective tumoricidal activity of this cytokine will still depend on intact IFN-γ signaling in RCC cells and, perhaps critically, on the ratio of IFN-γ receptor levels on RCC cells versus surrounding normal tissue.